DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1062939
Title:
Identification of Novel Signaling Pathways in NF2
Descriptive Note:
Technical Report,01 Jul 2017,30 Jun 2018
Corporate Author:
Cincinnati Childrens Hospital Cincinnati United States
Report Date:
2018-07-01
Pagination or Media Count:
10.0
Abstract:
Schwannomas are benign peripheral nerve tumors that are initiated by biallelic mutation of the NF2 tumor suppressor gene, resulting in loss of function of the NF2 gene product, merlin. Loss of merlin drives tumor formation but there is no consensus on the mechanism of merlins tumor suppressor function. Merlin has no intrinsic catalytic activity, its function regulated by the proteins with which it interacts. We used proximity biotinylation and direct binding assays to perform a global proteomic analysis that identified 52 merlin-associated proteins. The majority of merlin proximal proteins are components of cell junctional signaling complexes including actin binding proteins and members of the Hippo pathway. This pattern of protein interactions suggests that merlin functions as part of a mechano-sensory signal transduction network. We hypothesize that the loss of merlin destabilizes or impairs assembly of these structures, causing abnormal, cancer causing signals. To test this hypothesis, we will again use proximity biotinylation to look for changes in key cell junction components in the presence or absence of merlin. We expect that the experiments described in this proposal will yield greater insight
Distribution Statement:
APPROVED FOR PUBLIC RELEASE
